Researchers from Bar-Ilan University, led by Shahar Alon of the Faculty of Engineering, in conjunction with the Israeli Cancer Association published a study that reflects an advance in immune system technology developed to adapt the treatment of a cancer patient to their own body.
This is a new biotechnology that measures changes in the immune system cells surrounding cancer cells, showing how the patient's body responds to immunotherapy.
It is the first time that the interaction between immune and cancer cells has been able to be measured from a patient biopsy, and it was discovered that certain types of immune cells show a distinctive genetic signature when located near cancerous tissue.
Alon explained that “by quantifying the molecular changes that occur when immune cells encounter cancer cells, we gain a deeper understanding of this complex interaction,” adding that “this new understanding of the immune system's response to cancer cells promises more promising treatments.” effective and higher recovery rates.”